✦ LIBER ✦

A randomised, double-blind, controlled trial of the immunogenicity and tolerability of a meningococcal group C conjugate vaccine in young British infants

✍ Scribed by M. English; J.M. MacLennan; J.M. Bowen-Morris; J. Deeks; M. Boardman; K. Brown; S. Smith; J. Buttery; J. Clarke; S. Quataert; S. Lockhart; E.R. Moxon

Book ID: 117429997
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 122 KB
Volume: 19
Category: Article
ISSN: 0264-410X
DOI: 10.1016/s0264-410x(00)00241-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity and reactogenicity of a g

Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A+C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial

✍ Sharon Choo; Jane Zuckerman; Christian Goilav; Eva Hatzmann; Jan Everard; Adam F 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 252 KB

Double-blind vaccine-controlled randomis

Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults

✍ Dani Cohen; Shai Ashkenazi; Manfred S Green; Michael Gdalevich; Guy Robin; Rapha 📂 Article 📅 1997 🏛 The Lancet 🌐 English ⚖ 52 KB

Immunogenicity of bivalent types 1 and 3

Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial

✍ Roland W Sutter; T Jacob John; Hemant Jain; Sharad Agarkhedkar; Padmasani Venkat 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 299 KB

A randomized study comparing the safety

A randomized study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide—CRM197 with a meningococcal group C conjugate vaccine in healthy infants: Challenge phase

✍ Anna Riddell; Jim P. Buttery; Jodie McVernon; Tracey Chantler; Laura Lane; Jane 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 276 KB

Immunogenicity and safety of a new menin

Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2–10 years: A Phase II/III double-blind randomized controlled trial

✍ Siddhivinayak Hirve; Ashish Bavdekar; Anand Pandit; Sanjay Juvekar; Malini Patil 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 311 KB

Immunogenicity and tolerability of a mul

Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study

✍ María Elena Santolaya; Miguel L O'Ryan; María Teresa Valenzuela; Valeria Prado; 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 265 KB